Table 1.
Patients’ baseline characteristics (n = 64)
| Age (years) |
63 ± 8 |
| Women, n (%) |
32 (50) |
| Diabetes duration (years) |
9 ± 8 |
| Smoking habit, n (%) |
34 (53) |
| Past history of cardiovascular diseases, n (%) |
0 (0) |
| Family history of cardiovascular diseases, n (%) |
26 (41) |
| Systolic blood pressure (mmHg) |
128 ± 13 |
| Diastolic blood pressure (mmHg) |
76 ± 6 |
| Hypertension, n (%) |
41 (64) |
| Dyslipidemia, n (%) |
42 (66) |
| Obesity, n (%) |
28 (44) |
| Diabetic complications, n (%) |
16 (25) |
| Use of anti-hypertensive therapies |
|
| Beta-blockers, n (%) |
21 (33) |
| Angiotensin-converting enzyme inhibitors, n (%) |
15 (23) |
| Calcium entry blockers, n (%) |
12 (23) |
| Diuretics, n (%) |
20 (31) |
| Use of lipid-lowering drugs |
|
| Statins, n (%) |
26 (41) |
| Fibrates, n (%) |
9 (14) |
| Omega-3 fatty acids, n (%) |
12 (19) |
| Aspirin use, n (%) | 8 (13) |